Citations

Showing 10 of 108104 citations.

Computational Advances in the Label-free Quantification of Cancer Proteomics Data
Tang, Jing , Fu, Jianbo , Wang, Yunxia , Li, Yi , Yang, Qingxia , Yao, Lixia , Xue, Weiwei , Zhu, Feng , Zhang, Yang

Mayo Clinic

Current Pharmaceutical Design | November 2, 2018 | Volume: 24 | Issue: 32 | Pages: 3842-3858

10.2174/1381612824666181102125638 | PMID 30387388 Get It

Background: Due to its ability to provide quantitative and dynamic information on tumor genesis and development by directly profiling protein expression, the proteomics has become intensely popular for characterizing the functional proteins driving the transformation of malignancy, tracing the large-scale protein alterations induced by anticancer drug, and discovering the innovative targets and first-in-class drugs for oncologic disorders. Objective: To quantify cancer proteomics data, the label-free quantification (LFQ) is frequently employed. However, low precision, poor reproducibility and inaccuracy of the LFQ of proteomics data have been recognized as the key “technical challenge” in the discovery of anticancer targets and drugs. In this paper, the recent advances and development in the computational perspective of LFQ in cancer proteomics were therefore systematically reviewed and analyzed. Methods: PubMed and Web of Science database were searched for label-free quantification approaches, cancer proteomics and computational advances. Results: First, a variety of popular acquisition techniques and state-of-the-art quantification tools are systematically discussed and critically assessed. Then, many processing approaches including transformation, normalization, filtering and imputation are subsequently discussed, and their impacts on improving LFQ performance of cancer proteomics are evaluated. Finally, the future direction for enhancing the computation-based quantification technique for cancer proteomics are also proposed. Conclusion: There is a dramatic increase in LFQ approaches in recent year, which significantly enhance the diversity of the possible quantification strategies for studying cancer proteomics.
Synthesis and in Vivo Behavior of PVP/CMC/Agar Hydrogel Membranes Impregnated with Silver Nanoparticles for Wound Healing Applications
Lima, Gabriel Goetten de , Lima, Darlla W. F. de, Oliveira, Maria José Alves de , Lugão, Ademar B. , Alcantara, Mara T.S. , Devine, Declan M. , Sá, Marcelo Jorge Cavalcanti de , de Lima, Gabriel G , de Sá, Marcelo J C

Mayo Clinic

ACS Applied Bio Materials | November 2, 2018 | Volume: 1 | Issue: 6 | Pages: 1842-1852

10.1021/acsabm.8b00369 | PMID 34996285 Get It

Authors’ Reply
Sethi, Sanjeev , D’Agati, Vivette D. , Rajkumar, Vincent, Rajkumar, S. Vincent

Mayo Clinic

Journal of the American Society of Nephrology | November 2, 2018 | Volume: 29 | Issue: 12 | Pages: 2902-2902

10.1681/asn.2018101003 | PMID 30389728 Get It

Timing of Postoperative CSF Leak after Endoscopic Skull Base Surgery in Patients with Obstructive Sleep Apnea
Zimmermann, Terence M., Marcellino, Chris , O’Brien, Erin K. , Abel, Katie M. Van, Janus, Jeffrey R. , Link, Michael J., Frank, Ryan D. , Stokken, Janalee K., Marcellino, Chris R, Choby, Garret W, O'Brien, Erin K., O'Brien, Erin K , Marcellino, Christopher , Choby, Garret , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | November 1, 2018 | Volume: 80 | Issue: 04 | Pages: 392-398

10.1055/s-0038-1675588 | PMID 31316885 Get It

Background There is little data regarding postoperative outcomes of patients with obstructive sleep apnea (OSA) undergoing skull base surgery. The purpose of this study is to determine an association between risk factors and proximity of cerebrospinal fluid (CSF) leak to surgery in patients with OSA undergoing endoscopic skull base surgery. Methods A retrospective review of neurosurgical inpatients, with and without OSA, at a tertiary care institution from 2002 to 2015 that experienced a postoperative CSF leak after undergoing endoscopic skull base surgery. Results Forty patients met inclusion criteria, 12 (30%) with OSA. OSA patients had significantly higher body mass index (BMI; median 39.4 vs. 31.7, p < 0.01) and were more likely to have diabetes (41.7 vs. 10.7%, p = 0.04) than non-OSA patients; otherwise there were no significant differences in clinical comorbidities. No patients restarted positive pressure ventilation (PPV) in the inpatient setting. The type of repair was not a significant predictor of the time from surgery to leak. Patients with OSA experienced postoperative CSF leak 49% sooner than non-OSA patients (Hazard Ratio 1.49, median 2 vs. 6 days, log-rank p = 0.20). Conclusion Patients with OSA trended toward leaking earlier than those without OSA, and no OSA patients repaired with a nasoseptal flap (NSF) had a leak after postoperative day 5. Due to a small sample size this trend did not reach significance. Future studies will help to determine the appropriate timing for restarting PPV in this high risk population. This is important given PPV's significant benefit to the patient's overall health and its ability to lower intracranial pressure.
Role and future of MRI in radiation oncology
Das, Indra J. , McGee, Kiaran P. , Tyagi, Neelam , Wang, Hesheng , Das, Indra J.

Mayo Clinic

The British Journal of Radiology | November 1, 2018 | Volume: 92 | Issue: 1094 | Pages: 20180505

10.1259/bjr.20180505 | PMID 30383454 Get It

Higher intraoperative plasma transfusion volumes are associated with inferior perioperative outcomes
Frank, Ryan D. , Weister, Timothy J. , Stubbs, James R. , Kor, Daryl J. , Smith, Mark M. , Warner, Matthew A.

Mayo Clinic

Transfusion | November 1, 2018 | Volume: 59 | Issue: 1 | Pages: 112-124

10.1111/trf.14988 | PMID 30383908 Get It

BACKGROUNDIntraoperative plasma transfusion is common, yet little is known regarding its effects on perioperative coagulation tests or clinical outcomes.STUDY DESIGN AND METHODSThis is a retrospective cohort study of adults receiving intraoperative plasma transfusion at a single center from 2011 to 2015. Relationships between plasma transfusion volume, changes in coagulation test values, and clinical outcomes, including a primary outcome of early postoperative red blood cell (RBC) transfusion, were assessed with multivariable regression analyses. Secondary outcomes included hospital mortality, intensive care unit (ICU)‐ and hospital‐free days, intraoperative RBC transfusions, and estimated blood loss.RESULTSA total of 3393 unique patients were included, with median (IQR) transfusion of 2 (2‐4) units. In multivariable analyses, higher plasma volumes were associated with worse outcomes, with each 1 mL/kg increase associated with increased odds for postoperative (1.02 [1.01‐1.03], p < 0.001) and intraoperative RBCs (1.17 [1.16‐1.19], p < 0.001) and fewer ICU‐ and hospital‐free days (mean difference [95% CI], –0.08 [−0.12 to −0.05], p < 0.001; and −0.09 [−0.13 to −0.06], p < 0.001, respectively). Greater decreases in international normalized ratio (INR) following plasma transfusion were associated with decreased odds of postoperative RBCs (0.35 [0.25‐0.47], p < 0.001), decreased mortality (0.50 [0.31‐0.83], p = 0.007), and increased mean ICU‐ (1.31 [0.41‐2.21], p = 0.004) and hospital‐free days (1.15 [0.19‐2.10], p = 0.018).CONCLUSIONIn patients receiving intraoperative plasma transfusion, higher transfusion volumes were associated with inferior clinical outcomes; however, greater improvements in INR were associated with improved outcomes. Future prospective studies are necessary to better define these relationships and to explore plasma transfusion triggers beyond the limitations of INR.
Early-Phase Randomized Clinical Trials—Expectations vs Hard Reality
Knopman, David S.

Mayo Clinic

JAMA Neurology | November 1, 2018 | Volume: 76 | Issue: 1 | Pages: 15

10.1001/jamaneurol.2018.3301 | PMID 30383106 Get It

A 2-Year History of Diplopia, Optic Disc Edema, and Amaurosis
Cohen, Devon A. , Chen, John J. , Leavitt, Jacqueline A., Chen, John J

Mayo Clinic

JAMA Ophthalmology | November 1, 2018 | Volume: 137 | Issue: 1 | Pages: 103

10.1001/jamaophthalmol.2018.2604 | PMID 30383168 Get It

Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder
Behrendt‐møller, Ida , Madsen, Trine , Sørensen, Holger J. , Sylvia, Louisa G. , Friedman, Edward S., Shelton, Richard C. , Bowden, Charles L., Calabrese, Joseph R. , Ketter, Terence A. , Reilly-Harrington, Noreen A. , Gao, Keming , Thase, Michael E., Tohen, Mauricio , McInnis, Melvin G. , Kamali, Masoud , Kocsis, James H., Deckersbach, Thilo , Nierenberg, Andrew A. , Ketter, Terence A , Gao, Keming , V Bobo, William , Tohen, Mauricio , Kamali, Masoud , McInnis, Melvin G , McElroy, Susan L. , Bobo, William V. , Köhler‐Forsberg, Ole

Mayo Clinic

Bipolar Disorders | November 1, 2018 | Volume: 21 | Issue: 4 | Pages: 350-360

10.1111/bdi.12715 | PMID 30383333 Get It

IntroductionDepressive episodes are often prevalent among patients with bipolar disorder, but little is known regarding the differential patterns of development over time. We aimed to determine and characterize trajectories of depressive symptoms among adults with bipolar disorder during 6 months of systematic treatment.MethodsThe pragmatic clinical trial, Bipolar Clinical Health Outcomes Initiative in Comparative Effectiveness (CHOICE), randomized 482 outpatients with bipolar disorder to lithium or quetiapine. Depressive symptoms were rated at up to 9 visits using the Montgomery‐Asberg Depression Rating Scale (MADRS). Growth mixture modeling was utilized to identify trajectories and multinomial regression analysis estimated associations with potential predictors.ResultsFour distinct trajectories of depressive symptoms were identified. The responding class (60.3%) with a rapid reduction and subsequent low level; the partial‐responding class (18.4%) with an initial reduction followed by an increase during the remaining weeks; the fluctuating class (11.6%) with a fluctuation in depressive symptoms; and the non‐responding class (9.7%) with sustained moderate‐severe depressive symptoms. Bipolar type I predicted membership of the non‐responding class and randomization to quetiapine predicted membership of either the responding or the non‐responding class.ConclusionApproximately 30% experienced a partial or fluctuating course, and almost 10% had a chronic course with moderate‐severe depression during 6 months. Patients diagnosed with bipolar type 1 had higher risk of being categorized into a class with a worse outcome. While no differences in average overall outcomes occurred between the lithium and quetiapine groups, trajectory analysis revealed that the lithium group had more variable courses.
Unusual Cause of Severe Airflow Limitation in a Patient with Eisenmenger Syndrome
Nokes, Brandon , Jensen, Eric A., Cartin‐Ceba, Rodrigo

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | November 1, 2018 | Volume: 199 | Issue: 7 | Pages: e33-e34

10.1164/rccm.201805-0832im | PMID 30383401 Get It